As part of the settlement, CMS will allow states to exempt hospitals from the reporting requirement if the drugs are billed at no more than the purchasing cost. SNHPA filed the suit alleging that the reporting requirement would cost safety net hospitals that participate in the Section 340B federal drug discount program millions of dollars to implement. CMS will issue a clarification to Medicaid agencies within 30 days, according to the report.
Read the AHANews’ report on the CMS reversal on reporting drug codes.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
